Northwest Biotherapeutics (NASDAQ: NWBO) announced that the Company entered into agreement with Woodford Investment Management LLP ("Woodford"), as agent for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE